Author: Elizabeth Gregerson

Seattle-based Fred Hutch Cancer Center leader, John Thompson, MD, is retiring at year's end after serving at the organization for 40 years.

Detroit-based Wayne State University's Barbara Ann Karmanos Cancer Institute is the first facility in the world to prescribe a new at-home liver cancer treatment.

One Altamonte Springs, Fla.-based AdventHealth surgeon said his early years of playing video games influenced his surgical skills. 

Omaha-based Nebraska Medicine's Fred & Pamela Buffett Cancer Center officially opened the doors of its new location in Kearney, Neb., a city about 200 miles west of Omaha. 

Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center opened a $98 million cell and gene therapy hub aimed at growing the center's capabilities for cancer cell therapy research.

A 2023 shortage of the generic platinum-based chemotherapy drugs cisplatin and carboplatin had no effect on cancer mortality rates, according to a study published Dec. 3 in the Journal of the National Cancer Institute.

The University of Chicago Medicine Comprehensive Cancer Center has been awarded nearly $3 million in grants to expand two programs focused on diversity and equity in cancer research. 

Richmond-based Virginia Commonwealth University will establish a new research center focused on cancer equity with a five-year, $9 million National Cancer Institute grant.

Durham, N.C.-based Duke University Health System plans to establish a proton beam therapy center after receiving a $50 million gift from an anonymous donor.

The Cancer Institute at Tampa (Fla.) General Hospital has opened a new outpatient Cellular-Immunotherapy Transplant Unit, enabling some CAR T-cell and bone marrow transplant patients to continue living at home during treatment.